ENTITY
InnoCare Pharma Ltd

InnoCare Pharma Ltd (9969 HK)

96
Analysis
Health Care • China
InnoCare Pharma Limited researches, develops, manufactures, and distributes pharmaceuticals. The Company produces antibiotic drugs, respiratory drugs, cardiovascular drugs, vitamin tablets, health care drugs, and other related products. InnoCare Pharma markets its products throughout China.
more
bearish•HKEX
•24 Mar 2020 10:38

COVID-19: A Brutal Lesson in Sustainability and Systemic ESG Risk

The COVID-19 pandemic is, above all else, a human health crisis. But it's a multidimensional crisis that serves as a poignant lesson in global...

Logo
608 Views
Share
bullish•ByteDance
•22 Mar 2020 12:40

ECM Weekly (22 Mar 2020) - ByteDance, Topsports, Budweiser, Innocare, Shanghai Henlius

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. Even...

Share
bullish•InnoCare Pharma Ltd
•21 Mar 2020 21:00

InnoCare Pharma: Trading Debut, Valuation Scenario Analysis

InnoCare Pharma Ltd (9969 HK)Ā is a pre-revenue biotech company with a focus on research and development, manufacturing and commercialisation of...

Logo
409 Views
Share
bearish•InnoCare Pharma Ltd
•20 Mar 2020 12:21

InnoCare (čÆŗčÆšå„åŽ) IPO Trading: At the Mercy of Retail Flipping

InnoCare, a China-based biotech company founded by a famous scientist, raised USD 270 million at HKD 8.95 per share. In this insight, we will cover...

Logo
565 Views
Share
x